Glovadalen clinical trials
Also written UCB0022.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2021
How each study uses glovadalen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses glovadalen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Study to Assess the Safety and Tolerability, and Pharmacokinetics of UCB0022 in Healthy Caucasian, Japanese, and Chinese ParticipantsCompletedPhase 1UCB Biopharma SRLNCT06970301Written as glovadalen
- A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's DiseaseCompletedPhase 2UCB Biopharma SRLNCT06055985Written as UCB0022
- A Phase 1 Relative Bioavailability Study of UCB0022 Tablets in Healthy ParticipantsCompletedPhase 1UCB Biopharma SRLNCT07220551Written as UCB0022
- A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's DiseaseCompletedPhase 1UCB Biopharma SRLNCT04867642Written as UCB0022
Codes
What other systems call glovadalen · ClinicalTrials.gg INT016757
- UNII (FDA) H8T5VKH4CZGLOVADALENConfirmed FDA, Wikidata
- Wikidata Q129182538glovadalenConfirmed FDA, Wikidata
- NCI Thesaurus C206917GlovadalenOne source FDA
- DrugBank DB21709One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | H8T5VKH4CZ | GLOVADALEN | Confirmed FDA, Wikidata |
| Wikidata | Q129182538 | glovadalen | Confirmed FDA, Wikidata |
| NCI Thesaurus | C206917 | Glovadalen | One source FDA |
| DrugBank | DB21709 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.